Lymphatic filariasis
Finding a cure to end a disabling disease
Lymphatic filariasis
Finding a cure to end a disabling disease
We are working to develop a safe, effective, affordable treatment to help eliminate lymphatic filariasis.
Also known as elephantiasis due to the extreme swelling (lymphedema) that can result from the disease, lymphatic filariasis is caused by parasitic worms spread by the bites of infected mosquitoes. While people of all ages can get the disease, it’s most painful and disfiguring effects are only seen years after infection – and can result in social stigma, chronic ill health, and lifelong disability.
Mass drug administration over many years reduces transmission of the disease, but these treatments do not kill adult worms or reverse the long-term effects of infection.
India has committed to eliminating lymphatic filariasis by 2027 – and new treatments that kill both adult and juvenile worms could help the country achieve and sustain elimination.
‘I suffer from really painful attacks from the swelling in my legs.’
What we have achieved
R&D progress in the development of a macrofilaricide (a treatment able to kill adult worms) could benefit all filarial diseases. After testing oxfendazole for river blindness and other filarial diseases as part of the eWHORM consortium, DNDi is supporting partners now working to test the drug against lymphatic filariasis.
What we are doing for people with lymphatic filariasis
We aim to test and develop a new treatment that can prevent disability and help eliminate lymphatic filariasis as a public health problem.
Lymphatic filariasis news & resources
Elimination by 2027? India’s final push against lymphatic filariasis
Making medical history for neglected patients
We develop urgently needed treatments for neglected patients and ensure they’re affordable, available, and adapted to the communities who need them
Stay connected
Get our latest news, personal stories, research articles, and job opportunities.
